Company / Current Assets
RECURSION PHARMACEUTICALS, INC. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$812.8M
FY2025
5-year range
$438.1M / $812.8M
FY2021-FY2025
Trend
+13.8%
vs FY2024
Sector context
#68 of 213
Health Care
What the data says
At $813M, RECURSION PHARMACEUTICALS, INC.'s current assets ranks #68 of 213 in the Health Care sector. Improved from $438M to $813M over the past 2 years.
Based on SEC 10-K filings.
$813M in FY2025 with a 5-year CAGR of +25.0%.
Improved from $438M to $813M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- +25.0%
- 10-Year CAGR
- -
Sector benchmark
#68 of 213 in Health CareTop 32% of 213This company $812.8M Sector average $2.5B
▼
-67.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.0%, indicating consistent growth.
- In FY2025, current assets increased 13.8% year-over-year.
- Ranks #68 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $812.8M | +13.8% |
| FY2024 | $714.3M | +63.0% |
| FY2023 | $438.1M | -23.1% |
| FY2022 | $569.8M | +6.6% |
| FY2021 | $534.7M | +100.7% |
| FY2020 | $266.4M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026